Murphy Samuel Lafayette 4
4 · Viracta Therapeutics, Inc. · Filed Mar 30, 2021
Insider Transaction Report
Form 4
Murphy Samuel Lafayette
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-03-26+80,000→ 80,000 totalExercise: $8.74Exp: 2031-03-26→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]One thirty-sixth (1/36th) of the Shares subject to the Option shall vest on the one (1) month anniversary of March 1, 2021 (the "Vesting Commencement Date"), and one thirty-sixth (1/36th) of the Shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), subject to the reporting person continuing to be a Service Provider (as defined in the Viracta Therapeutics, Inc. 2021 Equity Incentive Plan) through each such date.